High throughput cross-interaction measures for human IgG1 antibodies correlate with clearance rates in mice

Although improvements in technology for the isolation of potential therapeutic antibodies have made the process increasingly predictable, the development of biologically active monoclonal antibodies (mAbs) into drugs can often be impeded by developability issues such as poor expression, solubility,...

Full description

Bibliographic Details
Main Authors: Sun, Tingwan (Author), Jain, Tushar (Author), Caffry, Isabelle (Author), Yu, Yao (Author), Lynaugh, Heather (Author), Brown, Michael (Author), Xu, Yingda (Author), Kelly, Ryan Lewis (Contributor), Vasquez, Maximiliano (Author), Wittrup, Karl Dane (Contributor), Cao, Yuan,Ph. D.Massachusetts Institute of Technology (Author)
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: Landes Bioscience, 2016-02-29T15:11:51Z.
Subjects:
Online Access:Get fulltext